NCT02055209 |
|
Genomics Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study GENE-FORECAST
|
View
|
NCT04191824 |
|
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States
|
View
|
NCT04910867 |
|
APOL1 Genetic Testing Program for Living Donors
|
View
|
NCT04999436 |
|
APOL1 Genetic Testing Program for Living Donors Part 2
|
View
|
NCT01442402 |
|
APOL1 Gene Variants in African American Kidney Transplant Recipients
|
View
|
NCT02006849 |
|
ACTH Treatment of APOL1- Associated Nephropathy
|
View
|
NCT02234063 |
|
Genetic Testing to Understand and Address Renal Disease Disparities
|
View
|
NCT05656261 |
|
APOL1 Genetic Testing in African Americans
|
View
|
NCT04340362 |
|
Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis
|
View
|
NCT06110130 |
|
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
|
View
|
NCT06116721 |
|
Evaluation of APOL1 Gene Variants in Kidney Donors and Their Impact on Long-term Renal Function in Donors and Recipients
|
View
|
NCT03615235 |
|
APOL1 Long-term Kidney Transplantation Outcomes Network APOLLO
|
View
|
NCT05214105 |
|
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
|
View
|
NCT05685810 |
|
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
|
View
|
NCT05237388 |
|
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
|
View
|
NCT05312879 |
|
Phase 23 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
|
View
|
NCT06443034 |
|
Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1
|
View
|
NCT04160507 |
|
Duke APOL1 Research Biorepository
|
View
|